Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases
Por um escritor misterioso
Last updated 16 junho 2024
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13023-018-0844-0/MediaObjects/13023_2018_844_Fig1_HTML.png)
Niemann-Pick disease type C (NP-C) is a rare, autosomal recessive, neurodegenerative disease associated with a wide variety of progressive neurological manifestations. Miglustat is indicated for the treatment of progressive neurological manifestations in both adults and children. Since approval in 2009 there has been a vast growth in clinical experience with miglustat. The effectiveness of miglustat has been assessed using a range of measures. Comprehensive review of published data from studies of cellular neuropathological markers and structural neurological indices in the brain, clinical impairment/disability, specific clinical neurological manifestations, and patient survival. Cranial diffusion tensor imaging and magnetic resonance spectroscopy studies have shown reduced levels of choline (a neurodegeneration marker), and choline/N-acetyl aspartate ratio (indicating increased neuronal viability) in the brain during up to 5 years of miglustat therapy, as well as a slowing of reductions in fractional anisotropy (an axonal/myelin integrity marker). A 2-year immunoassay study showed significant reductions in CSF-calbindin during treatment, indicating reduced cerebellar Purkinje cell loss. Magnetic resonance imaging studies have demonstrated a protective effect of miglustat on cerebellar and subcortical structure that correlated with clinical symptom severity. Numerous cohort studies assessing core neurological manifestations (impaired ambulation, manipulation, speech, swallowing, other) using NP-C disability scales indicate neurological stabilization over 2–8 years, with a trend for greater benefits in patients with older (non-infantile) age at neurological onset. A randomized controlled trial and several cohort studies have reported improvements or stabilization of saccadic eye movements during 1–5 years of therapy. Swallowing was also shown to improve/remain stable during the randomized trial (up to 2 years), as well as in long-term observational cohorts (up to 6 years). A meta-analysis of dysphagia – a potent risk factor for aspiration pneumonia and premature death in NP-C – demonstrated a survival benefit with miglustat due to improved/stabilized swallowing function. The effects of miglustat on neurological NP-C manifestations has been assessed using a range of approaches, with benefits ranging from cellular changes in the brain through to visible clinical improvements and improved survival.
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://www.mdpi.com/ijms/ijms-21-02533/article_deploy/html/images/ijms-21-02533-g001a.png)
IJMS, Free Full-Text
mRNA Treatment Rescues Niemann–Pick Disease Type C1 in Patient
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2F1750-1172-5-16/MediaObjects/13023_2009_Article_179_Fig1_HTML.jpg)
Niemann-Pick disease type C Orphanet Journal of Rare Diseases
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://www.mdpi.com/ijms/ijms-20-04392/article_deploy/html/images/ijms-20-04392-g001.png)
IJMS, Free Full-Text
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://assets.medlink.com/content/article-media/npmv2b.jpg)
Niemann-Pick disease type C
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://d3i71xaburhd42.cloudfront.net/903403ed7f2ca16be5230ab0ced49505dc4bf967/2-Figure1-1.png)
PDF] Miglustat for treatment of Niemann-Pick C disease: a
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://www.mdpi.com/jcm/jcm-09-00679/article_deploy/html/images/jcm-09-00679-g001.png)
JCM, Free Full-Text
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://www.neurology.org/cms/asset/8a836129-48b4-4d7b-a661-6883618bddad/wnl.2020.94.issue-16.largecover.jpg)
Imaging of neuroinflammation in adult Niemann-Pick type C disease
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://ars.els-cdn.com/content/image/1-s2.0-S0014482722001689-gr4.jpg)
Cytokine profile and cholesterol levels in patients with Niemann
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://casereports.bmj.com/content/casereports/2017/bcr-2017-220134/F3.large.jpg)
Patient with Niemann-Pick disease type C: over 20 years' follow-up
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://onlinelibrary.wiley.com/cms/asset/37fba022-c22c-4277-814d-23e17a739020/jimd12428-fig-0001-m.jpg)
Efficacy and safety of arimoclomol in Niemann‐Pick disease type C
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://encyclopedia.pub/media/item_content/202106/60d00c00942faijms-22-06600-g001-550.jpg)
Neurodegeneration in NPC Disease
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://d3i71xaburhd42.cloudfront.net/903403ed7f2ca16be5230ab0ced49505dc4bf967/3-Table2-1.png)
PDF] Miglustat for treatment of Niemann-Pick C disease: a
![Miglustat in Niemann-Pick disease type C patients: a review, Orphanet Journal of Rare Diseases](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs11096-022-01491-8/MediaObjects/11096_2022_1491_Fig2_HTML.png)
Cost-effectiveness of miglustat versus symptomatic therapy of
Recomendado para você
-
Niemann Pick Disease Type C - Symptoms, Causes, Treatment16 junho 2024
-
Doença de Niemann-Pick16 junho 2024
-
Mãe se torna enfermeira para cuidar do filho com doença rara: 'Ele16 junho 2024
-
Campanha “Pense de novo…” faz alerta aos médicos16 junho 2024
-
Enfermedad de Niemann-Pick: un enfoque global16 junho 2024
-
Proposed diagnostic algorithm for patients with suspected Niemann16 junho 2024
-
Doença de Gaucher Concise Medical Knowledge16 junho 2024
-
Relatório de caso: doença de Niemann-Pick com manifestações de16 junho 2024
-
Doença de Niemann-Pick tipo B: sinais e sintomas mais brandos16 junho 2024
-
Quais são os Sintomas da Doença de Niemann-Pick? Neurocirurgião16 junho 2024
você pode gostar
-
SeriousBW on X: Kaigaku and Zenitsu GFX Icon - Commissioned by Demonfall - Discord Link: - #robloxart #roblox #robloxgfx #robloxdev #robloxart - Likes and Retweets are Gladly Appreciated! / X16 junho 2024
-
Meme - Internet Thinking/Plotting MEDIUM (114x83mm) coolface troll face16 junho 2024
-
Studio Ghibli Animation GIF - Find & Share on GIPHY16 junho 2024
-
O que a crítica está achando de Halo Infinite? Veja notas16 junho 2024
-
Quebra-Cabeça Infantil Pinão em Madeira - Animais da Fazenda16 junho 2024
-
Programação da 62ª Festa do Peão de Barretos reúne principais16 junho 2024
-
Playmobil inspira nova série de animação no Canal Panda - Kids16 junho 2024
-
Vikings: Ragnar Lothbrok foi a morte mais chocante da série16 junho 2024
-
Pokémon TCG Tapu Koko GX Sun & Moon: Guardians Rising 135/145 Holo Full Art16 junho 2024
-
NEW* ALL WORKING CODES FOR BLADE BALL 2023 SEPTEMBER! ROBLOX BLADE16 junho 2024